Taken together, these findings suggest that MYC (over)expression in B cell lymphomas is an event that promotes tumor survival and aggressiveness of the disease through a complex interplay of different signaling pathways. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.